MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 08-18-2022
CureVac N.V. Current Ratio 2011-2026 | CVAC
Annual Current Ratio CureVac N.V.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.47 | 5.61 | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.61 | 2.47 | 4.04 |
Quarterly Current Ratio CureVac N.V.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 3.06 | 2.92 | 2.47 | 1.72 | - | - | 1.89 | - | - | - | 0.75 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.06 | 0.75 | 2.14 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M |  Canada |
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Adagene
ADAG
|
2.3 | $ 2.75 | -5.5 % | $ 155 M |  China |
 |
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | USA |
 |
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
1.5 | $ 81.68 | -0.39 % | $ 1.58 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Amgen
AMGN
|
1.44 | $ 341.02 | -0.56 % | $ 183 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
6.71 | - | - | $ 1.01 B | USA |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M |  France |
 |
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Aytu BioScience
AYTU
|
1.47 | $ 2.58 | 0.1 % | $ 16.2 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.18 | -2.45 % | $ 7.65 B |  Australia |
 |
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | USA |
 |
AVROBIO
AVRO
|
15.9 | - | 1083.1 % | $ 745 M | USA |
 |
Aptose Biosciences
APTO
|
0.69 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | USA |
 |
Biogen
BIIB
|
2.47 | $ 178.15 | 1.15 % | $ 25.9 B | USA |
 |
Brickell Biotech
BBI
|
5.28 | - | -5.38 % | $ 6.06 M | USA |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
Beam Therapeutics
BEAM
|
2.98 | $ 28.26 | -3.52 % | $ 2.33 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
0.918 | $ 225.58 | 0.73 % | $ 5 B |  Danmark |
 |
Athira Pharma
ATHA
|
4.22 | - | - | $ 269 M | USA |
 |
Atreca
BCEL
|
2.02 | - | -11.76 % | $ 5.79 M | USA |
 |
BioNTech SE
BNTX
|
7.22 | $ 114.21 | -2.2 % | $ 27.2 B | Germany |
 |
Burford Capital Limited
BUR
|
2.14 | $ 9.74 | 0.88 % | $ 1.52 B | Britain |
 |
Arrowhead Pharmaceuticals
ARWR
|
2.73 | $ 70.17 | 1.52 % | $ 9.39 B | USA |
 |
CASI Pharmaceuticals
CASI
|
4.56 | $ 1.0 | 1.5 % | $ 136 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | USA |
 |
Catalyst Biosciences
CBIO
|
3.06 | $ 9.97 | -1.77 % | $ 656 M | USA |
 |
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
6.32 | - | -9.72 % | $ 5.89 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.16 | - | -15.15 % | $ 60.3 M | Britain |
 |
Berkeley Lights
BLI
|
2.69 | - | -7.31 % | $ 87 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 4.05 | -1.22 % | $ 8.81 B |  Israel |
 |
Amneal Pharmaceuticals
AMRX
|
2.2 | $ 13.87 | -1.74 % | $ 4.29 B | USA |
 |
AIkido Pharma
AIKI
|
6.48 | - | 1.93 % | $ 17.4 M | USA |
 |
Bellerophon Therapeutics
BLPH
|
1.47 | - | -74.18 % | $ 955 K | USA |
 |
Cerus Corporation
CERS
|
1.4 | $ 2.34 | 0.65 % | $ 432 M | USA |
 |
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |
 |
Baudax Bio
BXRX
|
0.293 | - | 0.59 % | $ 63 K | USA |